StonvexLoading…
StonvexStonvexStonvexCore line items from NXPI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-29 | Annual 2025 2025-12-31 | Q3 2025 2025-09-28 | Q2 2025 2025-06-29 |
|---|---|---|---|---|
Revenue | $3.18B | $12.27B | $8.93B | $5.76B |
Operating Income | $1.50B | $3.05B | $2.30B | $1.41B |
Net Income | $1.12B | $2.02B | $1.57B | $935.00M |
EPS (Diluted) | $4.43 | $7.95 | $6.16 | $3.67 |
Total Assets | $27.11B | $26.56B | $26.35B | $25.25B |
Total Liabilities | $15.84B | $16.11B | $15.93B | $15.31B |
Cash & Equivalents | $3.71B | $3.27B | $3.45B | $3.17B |
Free Cash Flow OCF − CapEx | $714.00M | $2.42B | $1.63B | $1.12B |
Shares Outstanding | 253.53M | 254.33M | 254.40M | 254.43M |